Web-MAP Intervention for Youth With Sickle Cell Disease (Web-MAP)
WEB MAP Intervention for Youth With Sickle Cell Disease
The proposed study will determine whether the efficacy of WebMAP cognitive behavioral therapy (CBT) treatment study generalizes to pediatric sickle cell disease (SCD), and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population.
The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
調査の概要
詳細な説明
The proposed study will determine whether the efficacy of WebMAP generalizes to pediatric SCD, and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population.
The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Connecticut
-
Hartford、Connecticut、アメリカ、06106
- CCMC
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Documented sickle cell disease (verified by physician at SCD center if referred participant is a self referral)
- 11-18 years old
- Parental/patient consent and patient assent
- Internet and computer or smartphone access
- Score of >3 on the SCPBI-Y
Exclusion Criteria:
- Primary language spoken other than English
- 11<Age≤19
- Serious comorbid chronic condition (e.g., diabetes, arthritis, cancer)
- More than 4 sessions of outpatient behavioral therapy for pain management in the 6 months prior to the time of screening
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：処理
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：WEB-MAP CBT
Web-MAP Group.
Participants will have access to the full version of the web program.
They will be asked to log in to the website using their own personal computer at home, work, school, or a public library.
Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site.
The online treatment will take between 8 and 9 weeks for participants to complete.
Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation).
Adolescents and parents will be asked to complete a total of 8 modules each.
|
Web-MAP Group: Participants will have access to the full version of the web program.
They will be asked to log in to the website using their own personal computer at home, work, school, or a public library.
Participants in the Web-MAP group will have access to treatment modules and daily diaries on the web site.
The online treatment will take between 8 and 9 weeks for participants to complete.
Children and parents will be asked to log onto the web site, read through the treatment modules, and complete practice assignments to learn new skills (e.g., relaxation).
Adolescents and parents will be asked to complete a total of 8 modules each.
|
|
アクティブコンパレータ：WEB-MAP Educational Control Group
OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage.
This group will serve as an attention control condition.
Children will continue with the standard medical care that has been prescribed for their pain problem.
Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments.
This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.
|
OPEC (Online Patient Education Control) Group: The purpose of the patient education control group is to control for time, attention, and computer usage.
This group will serve as an attention control condition.
Children will continue with the standard medical care that has been prescribed for their pain problem.
Children and parents will be provided with access to a revised version of the Web-MAP study website, which will have two functional components: 1) information from publicly available educational websites about pediatric chronic pain management, 2) diary and assessments.
This version of the website differs from the one accessed by the treatment condition in that it does not provide access to behavioral and cognitive skills training via treatment modules for children and parents.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Efficacy in pain reduction
時間枠：6 months
|
We will compare pain intensity (pain scores), pain burden (Sickle Cell Pain Burden Interview), activity limitations (Child Activity Limitations Interview), quality of life (PedsQL), and health service use, and their corresponding changes from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study).
We will used a paired sample t-test.
|
6 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Efficacy of reducing depressive symptoms
時間枠：6 months
|
We will compare changes changes in depressive symptoms using the Centers for Epidemiological Study Depression scale from baseline to T2 (immediately after finishing the treatment arm) and T3 (6 months after enrollment in study).
We will used a paired sample t-test.
|
6 months
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Feasibility of WEB-MAP program
時間枠：6 months
|
We will conduct interviews with participants of the study using a script to start a dialogue on how user friendly their interface is, perceived difficulties or barriers, improvements to make, and general overall feedback to modify the program.
|
6 months
|
協力者と研究者
捜査官
- 主任研究者：William T Zempsky, MD, MPH、Connecticut Children's Medical Center
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- 13-032
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。